BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 16819399)

  • 21. Functional associations of genetic variants involved in the clinical manifestation of erythropoietic protoporphyria in the Argentinean population.
    Colombo FP; Rossetti MV; Méndez M; Martínez JE; Enríquez de Salamanca R; del C Batlle AM; Parera VE
    J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):754-62. PubMed ID: 22591014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical and molecular diagnosis of erythropoietic protoporphyria in an Ashkenazi Jewish family.
    Schneider-Yin X; Mamet R; Minder EI; Schoenfeld N
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S363-7. PubMed ID: 18758989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic study in a Singaporean patient with erythropoietic protoporphyria.
    Chuah SY; Tee SI; Pramono ZA; Theng CT
    Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):269-71. PubMed ID: 22971195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH.
    Gouya L; Puy H; Robreau AM; Bourgeois M; Lamoril J; Da Silva V; Grandchamp B; Deybach JC
    Nat Genet; 2002 Jan; 30(1):27-8. PubMed ID: 11753383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythropoietic protoporphyria.
    Lecha M; Puy H; Deybach JC
    Orphanet J Rare Dis; 2009 Sep; 4():19. PubMed ID: 19744342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incomplete erythropoietic protoporphyria caused by a splice site modulator homozygous IVS3-48C polymorphism in the ferrochelatase gene.
    Mizawa M; Makino T; Nakano H; Sawamura D; Shimizu T
    Br J Dermatol; 2016 Jan; 174(1):172-5. PubMed ID: 26280465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular epidemiology of erythropoietic protoporphyria in the U.K.
    Whatley SD; Mason NG; Holme SA; Anstey AV; Elder GH; Badminton MN
    Br J Dermatol; 2010 Mar; 162(3):642-6. PubMed ID: 20105171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical, Biochemical, and Genetic Characterization of North American Patients With Erythropoietic Protoporphyria and X-linked Protoporphyria.
    Balwani M; Naik H; Anderson KE; Bissell DM; Bloomer J; Bonkovsky HL; Phillips JD; Overbey JR; Wang B; Singal AK; Liu LU; Desnick RJ
    JAMA Dermatol; 2017 Aug; 153(8):789-796. PubMed ID: 28614581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of murine erythropoietic protoporphyria-associated skin photosensitivity and liver disease by dermal and hepatic ferrochelatase.
    Pawliuk R; Tighe R; Wise RJ; Mathews-Roth MM; Leboulch P
    J Invest Dermatol; 2005 Jan; 124(1):256-62. PubMed ID: 15654982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice.
    Barman-Aksözen J; C Wiek P; Bansode VB; Koentgen F; Trüb J; Pelczar P; Cinelli P; Schneider-Yin X; Schümperli D; Minder EI
    Dis Model Mech; 2017 Mar; 10(3):225-233. PubMed ID: 28093505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythropoietic protoporphyria: identification of novel mutations in the ferrochelatase gene and comparison of biochemical markers versus molecular analysis as diagnostic strategies.
    Frank J; Nelson J; Wang X; Yang L; Ahmad W; Lam H; Jugert FK; Kalka K; Poh-Fitzpatrick MB; Goerz G; Merk HF; Christiano AM
    J Investig Med; 1999 Jul; 47(6):278-84. PubMed ID: 10431482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exonic deletions as a cause of erythropoietic protoporphyria.
    Wood LH; Whatley SD; McKenna K; Badminton MN
    Ann Clin Biochem; 2006 May; 43(Pt 3):229-32. PubMed ID: 16704762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seasonal palmar keratoderma in erythropoietic protoporphyria indicates autosomal recessive inheritance.
    Holme SA; Whatley SD; Roberts AG; Anstey AV; Elder GH; Ead RD; Stewart MF; Farr PM; Lewis HM; Davies N; White MI; Ackroyd RS; Badminton MN
    J Invest Dermatol; 2009 Mar; 129(3):599-605. PubMed ID: 18787536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythropoietic protoporphyria a clinical and molecular study from Lebanon: Ferrochelatase a potential tumor suppressor gene in colon cancer.
    Kadara H; Nemer G; Safi R; Rebeiz N; Daou L; Delbani D; Btadini W; Abbas O; Tofaili M; Bitar F; Kibbi AG; Shimomura Y; Kurban M
    Clin Genet; 2017 Nov; 92(5):495-502. PubMed ID: 28075030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A homoallelic FECH mutation in a patient with both erythropoietic protoporphyria and palmar keratoderma.
    Minder EI; Schneider-Yin X; Mamet R; Horev L; Neuenschwander S; Baumer A; Austerlitz F; Puy H; Schoenfeld N
    J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1349-53. PubMed ID: 20337824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Congenital erythropoietic porphyria and erythropoietic protoporphyria: Identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations.
    Weiss Y; Balwani M; Chen B; Yasuda M; Nazarenko I; Desnick RJ
    Mol Genet Metab; 2019 Nov; 128(3):358-362. PubMed ID: 30454868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria.
    Gouya L; Martin-Schmitt C; Robreau AM; Austerlitz F; Da Silva V; Brun P; Simonin S; Lyoumi S; Grandchamp B; Beaumont C; Puy H; Deybach JC
    Am J Hum Genet; 2006 Jan; 78(1):2-14. PubMed ID: 16385445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel null-allele mutations and genotype-phenotype correlation in Argentinean patients with erythropoietic protoporphyria.
    Parera VE; Koole RH; Minderman G; Edixhoven A; Rossetti MV; Batlle A; de Rooij FW
    Mol Med; 2009; 15(11-12):425-31. PubMed ID: 19693296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Photosensitivity and acute liver injury in myeloproliferative disorder secondary to late-onset protoporphyria caused by deletion of a ferrochelatase gene in hematopoietic cells.
    Goodwin RG; Kell WJ; Laidler P; Long CC; Whatley SD; McKinley M; Badminton MN; Burnett AK; Williams GT; Elder GH
    Blood; 2006 Jan; 107(1):60-2. PubMed ID: 16150949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 10376 bp deletion of FECH gene responsible for erythropoietic protoporphyria.
    Di Pierro E; Brancaleoni V; Besana V; Ausenda S; Drury S; Cappellini MD
    Blood Cells Mol Dis; 2008; 40(2):233-6. PubMed ID: 17888693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.